Mr. Yon is a transactional and licensing lawyer with extensive experience in funding and licensing technology for biotechnology and pharmaceutical companies. He has negotiated and closed more than 50 major (>$1 million) licensing, distribution and collaboration agreements with pharmaceutical, biotechnology, medical device and clean energy companies. He has represented major research institutes and educational institutions and has licensed technology from leading research universities.
Mr. Yon serves as outside General Counsel for several of his clients. He provides licensing, regulatory and compliance advice, antitrust analysis, contract review and business strategies advice to his clients.
Publications/Speeches
Mr. Yon is a frequent speaker at Licensing Executive Society, American Conference Institute and Practicing Law Institute conferences on licensing, indemnification, product liability and clinical trial issues
|
|
| Mr. Yon was Senior Vice President, General Counsel and Secretary at Coley Pharmaceutical Group from 2001 through 2008 where he was responsible for all legal and regulatory matters, including patent prosecution and litigation strategy. Coley completed the largest biotech IPO in 2005 ($120 million) and raised approximately $100 million in private round equity investments. Mr. Yon was the co-leader of the team which negotiated and completed the sale of Coley to Pfizer in 2008 for $250,000,000. |
|
| Representative Experience | |
| Professional/Community Affiliations | |
- Incorporator and member of the Board of Visitors New England Baptist Hospital
- Former Vice Chair of Sherborn Advisory (finance) Committee
- Advisory Committee to Vacations That Give
- Member of St. Theresa Parish Pastoral Council
|
|
| 6/17/10 | David Viens and Charles E. Yon Join the Firm |
|
| | B.A., 1972, cum laude, Harvard College | | J.D., 1977, Georgetown University Law Center |
|
|